High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants

Planta

Volumn 231, Issue 2, 2010, Pages 387-395

  Lentz, Ezequiel Matías ^a   Segretin, María Eugenia ^a   Morgenfeld, Mauro Miguel ^a   Wirth, Sonia Alejandra ^a   Santos, María José Dus ^b   Mozgovoj, Marina Valeria ^b   Wigdorovitz, Andrés ^b   Bravo Almonacid, Fernando Félix ^a  

^a Laboratorio de Virologia Ciudad Autonoma de Buenos Aires   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

Author keywords

Antigen; Foot and mouth disease virus; Molecular farming; Plastid transformation; Tobacco

Indexed keywords

BETA GLUCURONIDASE; CAPSID PROTEIN; EPITOPE; VEGETABLE PROTEIN; VP1 PROTEIN, FOOT AND MOUTH DISEASE VIRUS; VP1 PROTEIN, FOOT-AND-MOUTH DISEASE VIRUS;

ANIMAL; ARTICLE; CHEMISTRY; CHLOROPLAST; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; GENE VECTOR; GENETIC TRANSFORMATION; GENETICS; IMMUNOLOGY; METABOLISM; MOUSE; PHENOTYPE; TOBACCO; TRANSGENIC PLANT; VIROLOGY;

ANIMALS; CAPSID PROTEINS; CHLOROPLASTS; EPITOPES; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; GLUCURONIDASE; MICE; PHENOTYPE; PLANT PROTEINS; PLANTS, GENETICALLY MODIFIED; TOBACCO; TRANSFORMATION, GENETIC;

FOOT-AND-MOUTH DISEASE VIRUS; MUS; NICOTIANA TABACUM;

EID: 77949774705     PISSN: 00320935     EISSN: 14322048     Source Type: Journal    
DOI: 10.1007/s00425-009-1058-4     Document Type: Article

References (36)

1. Bachrach H (1977) Foot and mouth disease virus: properties, molecular biology and immunogenicity. In: Romberger (ed) Betsville symposia in agricultural research I. Virology in agriculture. Allanheld-Osmiun, Montclair, NY, pp 3-32.
2. Bock R (2007) Plastid biotechnology: prospect for herbicide and insect resistance, metabolic engineering and molecular farming. Curr Opin Biotechnol 18: 100-106.
3. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Chebolu S, Daniell H (2007) Stable expression of Gal/GalNAc lectin of Entamoeba histolytica in transgenic chloroplasts and immunogenicity in mice towards vaccine development for amoebiasis. Plant Biotechnol J 5: 230-239.
5. Church GM, Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995.
6. Daniell H (2006) Production of biopharmaceuticals and vaccines in plants via the chloroplast genome. Biotechnol J 1: 1071-1079.
7. Daniell H, Lee SB, Panchal T, Wiebe PO (2001) Expression of cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts. J Mol Biol 311: 1001-1009.
8. De Cosa B, Moar W, Lee S, Miller M, Daniell H (2001) Overexpression of the Bt cry2Aa2 operon in chloroplasts leads to formation of insecticidal crystals. Nat Biotechnol 19: 71-74.
9. Dellaporta SL, Chomet PS, Mottinger JP, Wood JA, Yu SM, Hicks JB (1984) Endogenous transposable elements associated with virus infection in maize. Cold Spring Harb Symp Quant Biol 49: 321-328.
10. Dus Santos MJ, Wigdorovitz A, Trono K, Ríos RD, Franzone PM, Gil F, Moreno J, Carrillo C, Escribano JM, Borca MV (2002) A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine 20: 1141-1147.
11. Fernández-San Millan A, Ortigosa SM, Hervas-Stubbs S, Corral-Martinez P, Segui-Simarro JM, Gaetan J, Coursaget P, Veramendi J (2008) Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic. Plant Biotechnol J 6: 427-441.
12. Floss DM, Falkenburg D, Conrad U (2007) Production of vaccines and therapeutic antibodies for veterinary applications in transgenic plants: an overview. Trans Res 16: 315-332.
13. Grubman MJ, Baxt B (2004) Foot and mouth. Dis Clin Microbiol Rev 17: 465-493.
14. Hager M, Biehler K, Illerhaus J, Ruf S, Bock R (1999) Targeted inactivation of the smallest plastid genome-encoded open reading frame reveals a novel and essential subunit of the cytochrome b(6)f complex. EMBO J 18(21): 5834-5842.
15. Herz S, Füßl M, Steiger S, Koop H (2005) Development of novel types of plastid transformation vectors and evaluation of factors controlling expression. Trans Res 14: 969-982.
16. Hondred D, Walker JM, Mathews DE, Vierstra RD (1999) Use of ubiquitin fusions to augment protein expression in transgenic plants. Plant Physiol 119: 713-723.
17. Jefferson RA, Kavanagh TA, Bevan MW (1987) GUS-fusions: β-glucuronidase as a sensitive and versatile gene fusion marker in higher plants. EMBO J 6: 3901-3907.
18. Joensuu JJ, Kiklander-Teeri V, Brandle JE (2008) Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control. Phytochem Rev 7: 553-577.
19. Koya V, Moayeri M, Leppla SH, Daniell H (2005) Plant based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge. Infect Immun 73: 8266-8274.
20. Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
21. LaVallie ER, McCoy JM (1995) Gene fusion expression systems in Escherichia coli. Curr Opin Biotechnol 6: 501-506.
22. Leelavathi S, Reddy VS (2003) Chloroplast expression of His-tagged GUS-fusions: a general strategy to overproduce and purify foreign proteins using transplastomic plants as bioreactors. Mol Breed 11: 49-58.
23. Li Y, Sun M, Liu J, Yang Z, Zhang Z, Shen G (2005) High expression of foot-and-mouth disease virus structural protein VP1 in tobacco chloroplasts. Plant Cell Rep 25(4): 329-333.
24. McCabe MS, Klaas M, Gonzalez-Rabade N, Poage M, Badillo-Corona JA, Zhou F, Karcher D, Bock R, Gray JC, Dix PJ (2008) Plastid transformation of high-biomass tobacco variety Maryland Mammoth for production of human immunodeficiency virus type 1 (HIV-1) p24 antigen. Plant Biotechnol J 6: 914-929.
25. Molina A, Hervás-Stubbs S, Daniell H, Mingo-Castel AM, Veramendi J (2004) High-yield expression of a viral peptide animal vaccine in transgenic tobacco chloroplasts. Plant Biotechnol J 2: 141-153.
26. Oey M, Lohse M, Kreikemeyer B, Bock R (2009) Exhaustion of the chloroplast protein synthesis capacity by massive expression of a highly stable protein antibiotic. Plant J 57: 436-445.
27. Ruf S, Biehler K, Bock R (2000) A small chloroplast-encoded protein as a novel architectural component of the light-harvesting antenna. J Cell Biol 149(2): 369-378.
28. Rybicki EP (2009) Plant-produced vaccines: promise and reality. Drug Disc Today 14: 16-24.
29. Sobrino F, Sáiz M, Jiménez-Clavero MA, Núñez JI, Rosas MF, Baranowski E, Ley V (2001) Foot-and-mouth disease virus: a long known virus, but a current threat. Vet Res 32: 1-30.
30. Svab Z, Maliga P (1993) High-frequency plastid transformation by selection for a chimeric aadA gene. Proc Natl Acad Sci USA 90: 913-917.
31. Svab Z, Hajdukiewicz P, Maliga P (1990) Stable transformation of plastid in higher plants. Proc Natl Acad Sci USA 87: 8526-8530.
32. Tregoning JS, Nixon P, Kuroda H, Svab Z, Clare S, Bowe F, Fairweather N, Ytterberg J, Wijk KJ, Dougan G, Maliga P (2003) Expression of tetanus toxin fragment C in tobacco chloroplasts. Nucleic Acids Res 31: 1174-1179.
33. Vermij P, Waltz E (2006) USDA approves the first plant-based vaccine. Nat Biotechnol 24: 233-234.
34. Wigdorovitz A, Carrillo C, Dus Santos MJ, Sadir AM, Ríos R, Franzone P (1999) Induction of a protective antibody response to foot and mouth disease virus in mice following oral or parenteral immunized with alfalfa transgenic plants expressing the viral structural protein VP1. Virology 255: 347-353.
35. Wirth S, Segretin ME, Mentaberry A, Bravo-Almonacid FF (2006) Accumulation of hEGF and hEGF-fusion proteins in chloroplast-transformed tobacco plants is higher in the dark than in the light. J Biotechnol 125: 159-172.
36. Zhou F, Badillo-Corona JA, Karcher D, Gonzalez-Rabade N, Piepenburg K, Borchers AM, Maloney AP, Kavanagh TA, Gray JC, Bock R (2008) High-level expression of human immunodeficiency virus antigens from the tobacco and tomato plastid genomes. Plant Biotechnol J 6: 897-913.